Stl Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.78 Cr
as on 17-06-2024
- Satisfied Charges ₹ 6.40 Cr
as on 17-06-2024
- Revenue 22.49%
(FY 2022)
- Profit -41.99%
(FY 2022)
- Ebitda -21.68%
(FY 2022)
- Net Worth 13.20%
(FY 2022)
- Total Assets 4.09%
(FY 2022)
About Stl Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.78 Cr. The company has closed loans amounting to ₹6.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sejal Dave, Viral Dave, and Jitendra Dave serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC201926
- Company No.
201926
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Stl Pharma Private Limited offer?
Stl Pharma Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement, Ayurvedic & Herbal Extracts, Herbal Extracts, Common Disease Medicines, Antihistamines, Essential & Aromatic Oils, Carrier Oil.
Who are the key members and board of directors at Stl Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sejal Dave  | Director | 30-Jan-2024 | Current |
| Viral Dave | Director | 12-Apr-2010 | Current |
| Jitendra Dave | Director | 12-Apr-2010 | Current |
Financial Performance of Stl Pharma.
Stl Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.49% increase. The company also saw a substantial fall in profitability, with a 41.99% decrease in profit. The company's net worth Soared by an impressive increase of 13.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stl Pharma?
In 2021, Stl Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 18 Oct 2022 | ₹7.72 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Feb 2021 | ₹0.57 M | Open |
Hdfc Bank Limited Creation Date: 30 Sep 2014 | ₹6.40 Cr | Satisfied |
How Many Employees Work at Stl Pharma?
Stl Pharma has a workforce of 54 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stl Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stl Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
